With IHC staining, we confirmed that E2 treatment decreased the Ki-67 positive tumor cells, reduced NOTCH3 expression, lessened M2 infiltration and increased CD8+ T cell infiltration (Figure 4G–H). The gene discussed is NOTCH3; the disease is neoplasm.